All Online

1 - 12 of 63 results

Refine

Active filters

Diabetes
purple and grey needle stacks

This activity will discuss how primary clinicians can address barriers to early initiation and appropriate intensification of insulin in patients with T2DM; recommend appropriate basal insulin regimens based on patients’ clinical needs, hypoglycemia risk, and drug clinical profile; and be aware of new and emerging basal insulins, which may have the potential of improving T2DM treatment and patient outcomes.


0.75 CME CREDIT

sugar stacked with the word diabetes

The expanded number of therapies with varying mechanisms of action for type 2 diabetes has resulted in novel combination regimens for patients not achieving goals despite therapy with metformin. Dr. Serge Jabbour will review novel combinations and approaches to intensifying therapy in this interactive case study.


ACHL Diabetes Patient Case Study

Diabetes continues to have a significant impact on morbidity and mortality in the United States, and is an ongoing treatment challenge for primary care providers who lack confidence with treatment intensification including newer agents and combination therapies resulting in clinical inertia. Further, approaches to improved adherence and lifestyle modification through shared-decision making continue to evolve with the goal of improving quality of care.


In this interactive case study, Dr. Richard Pratley, Medical Director of the Florida Diabetes Institute, walks through the clinical decision-making process for a 60-year-old African American woman with type 2 diabetes whose diabetes is progressing despite metformin therapy. Dr. Pratley examines factors likely contributing to this patient's poor glycemic control, as well as steps for intensification of therapy beyond metformin and considerations for treatment selection, such as risk for hypoglycemia and cardiovascular issues.


In this case presentation, Kathleen Wyne, MD, PhD, Associate Professor of Clinical Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University College of Medicine shares strategies for intensification of diabetes management that incorporate real life patient challenges with evidence based medicine to develop a regimen that is likely to attain the patient’s A1C target. These strategies include working with what the patient is actually willing to do while trying to attain A1C target, with consideration to importance of controlling both fasting and postprandial glucose in patients with type 2 diabetes, and the use of GLP-1 receptor agonists in combination with basal insulin for optimal glycemic control in patients who require intensification of therapy.


1.5 CME CREDITS

In this Virtual Expert Roundtable, moderator Mary Lindholm, MD, of UMass Medical Center, along with faculty Intekhab Ahmed, MD, FACE, FACP, of Thomas Jefferson University, and Felice Caldarella, MD, FACE, FACP, CDE, of Hunterdon Medical Center, discuss how and when providers should consider adding a GLP-1 receptor agonist to basal insulin for the treatment of type 2 diabetes. They will discuss the differences between short-acting and long-acting GLP-1 receptor agonists and the practical aspects of adding a GLP-1 receptor agonist to basal insulin therapy, as well as the latest data on emerging fixed-ratio formulations of GLP-1 receptor agonists and basal insulin.